 
       
	Executive Interviews
Investing For Life: Q&A With Sofinnova Chairman Antoine Papiernik
				Paris-based Sofinnova Partners, a life science venture capital firm, has been an early investor in companies such Genentech and Biogen, and now has over $2.5 billion invested in sciences, primarily in healthcare and sustainability. Antoine Papiernik, Sofinnova chairman and managing partner, speaks with Global Finance about the state of life sciences today and in future.			
		
	 
     
     
     
     
     
     
     
     
     
    